FISHER CLINICAL SERVICES UK LIMITED

1. FISHER CLINICAL SERVICES UK LIMITED 2007-05-29 → present
2. OXOID INVESTMENT HOLDINGS LIMITED 2004-11-09 → 2007-05-29

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The company meets its day-to-day working capital requirements through its bank facilities. The current economic conditions continue to create uncertainty over (a) the level of demand for the company's products; and (b) the availability of bank finance for the foreseeable future. The company's forecasts and predictions, taking account of reasonably possible changes in trading performance, show that the company should be able to operate within the level of its current liabilities. After making enquiries, the directors have a reasonable expectation that the company has access to adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.”

Group structure

1. FISHER CLINICAL SERVICES UK LIMITED · parent
   1. Fisher Clinical Services PTE Limited 100% · Singapore · Trading
   2. Fisher Biopharma services (India) Private Limited 0.315% · India

Significant events

• “On 28 January 2025 the term of the intercompany loan payable of £12,520,000 owed to Fisher Scientific UK Holding Company was extended to 5 December 2025, effective 5 December 2024.”
• “Furthermore, on 22 December 2025, the loan and associated accrued interest, totaling £14,587,600 was repaid in full.”
• “On 22 December 2025 a dividend of £19,500,000 was declared and paid.”
• “On 22 December 2025 the company also received a dividend of £6,634,000 from its subsidiary undertaking.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +0.6%

  £144,479,000 → £145,363,000

• Cash

  +48.2%

  £110,000 → £163,000

• Net assets

  -10.7%

  £91,510,000 → £81,710,000

• Employees

  -9.7%

  733 → 662

• Operating profit

  +10.2%

  £32,104,000 → £35,391,000

• Profit before tax

  -12%

  £63,889,000 → £56,227,000

• Wages

  -3.7%

  £30,094,000 → £28,973,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers